Q4 2025 Management View CEO Robert Spignesi announced a new multisystem order from Samsung Biologics in Q1 2026, stating this "expansion yet again highlights the impact that Growth Direct delivers to ...
This article first appeared on GuruFocus. Rapid Micro Biosystems Inc (NASDAQ:RPID) is set to release its Q4 2025 earnings on Mar 12, 2026. The consensus estimate for Q4 2025 revenue is $11.35 million, ...
Reports record fourth quarter 2025 total revenue of $11.3 million , representing 37% growth compared to fourth quarter 2024 Reports full ...
Rapid Micro Biosystems, Inc. sees strong FY25 revenue growth from Growth Direct placements, but losses persist. Click for ...
Rapid Micro Biosystems (NASDAQ:RPID) reported fourth-quarter and full-year 2025 results highlighting record quarterly revenue ...
This follow-on order builds on the companies’ existing partnership and supports Samsung’s continued expansion of the Growth ...
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Q4 2025 Earnings Call Transcript March 12, 2026 Rapid Micro Biosystems, Inc. misses on earnings expectations. Reported EPS is $-0.2801 EPS, expectations were ...
Rapid Micro Biosystems (NASDAQ:RPID) is preparing to release its quarterly earnings on Friday, 2025-05-09. Here's a brief overview of what investors should keep in mind before the announcement.
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.26 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.31 per share a year ago. These figures are ...
LOWELL, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results